Estimated antiretroviral therapy coverage among children in AMR
AMR: Estimated antiretroviral therapy coverage among children was 48 in 2025. ◆ Volatile
Latest (2025)
48
Change on year
up 9.1%
Rank
4th
of 7 groups
All-time high
48
in 2025
All-time low
4
in 2000
Years of data
26
2000–2025
Estimated antiretroviral therapy coverage among children in AMR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
AMR recorded 48 for estimated antiretroviral therapy coverage among children in 2025. That is the highest value across all 26 years on record.
That represents a change of up 9.1% on the previous year and up 20.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among children in AMR peaked at 48 in 2025 and was at its lowest, 4, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among children in AMR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 4 | — |
| 2001 | 5 | +25.0% |
| 2002 | 6 | +20.0% |
| 2003 | 8 | +33.3% |
| 2004 | 9 | +12.5% |
| 2005 | 10 | +11.1% |
| 2006 | 12 | +20.0% |
| 2007 | 14 | +16.7% |
| 2008 | 17 | +21.4% |
| 2009 | 30 | +76.5% |
| 2010 | 32 | +6.7% |
| 2011 | 34 | +6.2% |
| 2012 | 36 | +5.9% |
| 2013 | 36 | +0.0% |
| 2014 | 38 | +5.6% |
| 2015 | 40 | +5.3% |
| 2016 | 39 | -2.5% |
| 2017 | 41 | +5.1% |
| 2018 | 41 | +0.0% |
| 2019 | 43 | +4.9% |
| 2020 | 44 | +2.3% |
| 2021 | 44 | +0.0% |
| 2022 | 44 | +0.0% |
| 2023 | 44 | +0.0% |
| 2024 | 44 | +0.0% |
| 2025 | 48 | +9.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.5 | 4 | 30 | 10 |
| 2010s | 38 | 32 | 43 | 10 |
| 2020s | 44.67 | 44 | 48 | 6 |
Countries ranked near AMR
More health data for AMR
- Mortality rate among children ages 5 to 9 years 1.08 (2024)
- Population with primary reliance on polluting fuels and technologies 42.21 (2023)
- Prevalence of diabetes, crude 14.59 (2022)
- Population with primary reliance on fuels and technologies for 37.18 (2023)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 92.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 88.0% (2025)
- New HIV infections 0.18 (2025)
- Stunting prevalence among children under 5 years of age (%) 9.9% (2024)
- Mean total cholesterol, crude 4.7 (2018)
- Adolescent mortality rate 1.27 (2021)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among children in AMR?
- Estimated antiretroviral therapy coverage among children in AMR was 48 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among children recorded in AMR?
- The highest recorded value was 48 in 2025.
- What is the lowest estimated antiretroviral therapy coverage among children recorded in AMR?
- The lowest recorded value was 4 in 2000.
- How does AMR rank for estimated antiretroviral therapy coverage among children?
- AMR ranks 4th out of 7 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among children rising or falling in AMR?
- Over the last ten years it is up 20.0%. The long-run trend across the full record is volatile.
- Where does this AMR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among children. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).